Flonase (Fluticasone Propionate) Nasal Spray: Comprehensive Clinical Guide
Indications
Fluticasone propionate nasal spray is indicated for both seasonal and perennial allergic rhinitis, effectively treating nasal congestion, rhinorrhea, sneezing, itchy nose, and itchy/watery eyes. 1, 2
- Approved for adults, adolescents ≥12 years, and children as young as 4 years of age 1, 2
- Effective for year-round allergen exposure (dust, pet dander, mold) and seasonal allergens (pollen) 2
Recommended Dosing
Adults and Adolescents (≥12 years)
Start with 2 sprays per nostril once daily (200 mcg total) for the first week, then reduce to 1–2 sprays per nostril once daily as needed for symptom control. 1, 2
- Maximum duration without physician consultation: 6 months of daily use 2
- For severe nasal congestion unresponsive to standard dosing, may temporarily increase to 2 sprays per nostril twice daily (400 mcg total) until symptoms are controlled, then taper to maintenance 1
Children (4–11 years)
Use 1 spray per nostril once daily (100 mcg total). 1, 2
- An adult should supervise administration 2
- Maximum duration without physician consultation: 2 months per year 2
- Important caveat: Long-term intranasal corticosteroids may slow growth rate in some children; use the shortest duration necessary to achieve symptom relief 3, 2
- Studies show no growth effects at recommended doses with fluticasone propionate, mometasone furoate, and budesonide 3
Children (<4 years)
Do not use. 2
- Alternative options for children 2–3 years: mometasone furoate or triamcinolone acetonide are FDA-approved for this age group 1, 3
Administration Technique
Proper technique is critical to maximize efficacy and minimize side effects, particularly epistaxis. 1
Step-by-Step Instructions
- Prime the bottle before first use by shaking and spraying away from face until a fine mist appears 1
- Shake gently before each use 1, 2
- Blow nose prior to administration 1
- Keep head upright during administration 1
- Use contralateral hand technique: Hold the spray in the opposite hand relative to the nostril being treated (right hand for left nostril, left hand for right nostril) to direct spray away from the nasal septum—this reduces epistaxis risk by fourfold 1, 3
- Breathe in gently during spraying 1
- Do not close the opposite nostril during administration 3
- If using nasal saline irrigations, perform them before administering fluticasone to avoid rinsing out the medication 1
Onset of Action and Treatment Expectations
Symptom relief typically begins within 12 hours, with some patients experiencing benefit as early as 3–4 hours, but maximal efficacy requires several days to weeks of continuous daily use. 1, 4
- Critical patient counseling point: This is maintenance therapy, not rescue therapy—continue regular use even when symptoms improve 1, 2
- For predictable seasonal allergies, initiate treatment before symptom onset and continue throughout allergen exposure 1
- Unlike topical decongestants (limited to 3 days), fluticasone does not cause rebound congestion and is safe for long-term daily use 1, 3
Contraindications
Absolute contraindication: History of hypersensitivity to fluticasone propionate or any component of the formulation. 1, 3, 2
Medications Requiring Caution
Consult physician or pharmacist before use if taking: 2
- HIV protease inhibitors (e.g., ritonavir)—may increase fluticasone levels
- Ketoconazole (oral antifungal)—may increase fluticasone levels
- Other systemic corticosteroids for asthma, allergies, skin conditions, or eye disorders—cumulative steroid exposure
Important Cautions and Monitoring
Long-Term Use Safety
Fluticasone propionate demonstrates excellent long-term safety with no clinically significant systemic effects at recommended doses. 3, 4
- No HPA axis suppression in children or adults 3, 5, 4
- No growth suppression at recommended doses (unlike beclomethasone dipropionate, which should be avoided in children) 3
- No ocular effects (cataracts, glaucoma, elevated intraocular pressure) with long-term use 3
- No bone density effects 4
- Studies demonstrate safety for up to 52 weeks of continuous use 1
Monitoring Requirements
- Periodic nasal septum examination (every 6–12 months during long-term use) to detect mucosal erosions that may precede septal perforation 1, 3
- If no improvement after 3 months of therapy, consider CT imaging, short course of oral corticosteroids, or surgical evaluation 1
Pediatric-Specific Cautions
- Growth rate monitoring is prudent, though studies show no effect at recommended doses 3, 2
- Limit duration to shortest time necessary for symptom control 2
- Physician consultation required if use exceeds 2 months per year 2
Common Adverse Effects
Local Side Effects (Most Common)
Epistaxis (nosebleeds) is the most frequent adverse event, typically presenting as blood-tinged nasal secretions rather than severe bleeding. 1, 3
- Occurs in 4–8% of patients in short-term studies, up to 20% with year-long use 3
- Minimize risk: Use contralateral hand technique to direct spray away from septum 1, 3
Other common local effects: 1, 3
- Nasal burning or irritation
- Headache
- Pharyngitis (throat irritation)
- Nausea or vomiting
- Cough
- Asthma symptom exacerbation (rare)
Rare but Serious
Important Clarification
Fluticasone nasal spray does NOT cause: 3, 2
- Elevated blood pressure (unlike oral decongestants)
- Constipation (if present, evaluate other medications, particularly oral antihistamines with anticholinergic effects)
- Systemic corticosteroid side effects at recommended doses
Clinical Efficacy and Comparative Effectiveness
Intranasal corticosteroids are the single most effective medication class for allergic rhinitis, superior to oral antihistamines, leukotriene receptor antagonists, and combination therapy with multiple oral agents. 1, 3
- Fluticasone propionate once daily is as effective as twice-daily dosing 6, 7
- Fluticasone propionate once daily is as effective as beclomethasone dipropionate twice daily 6, 7
- More effective than oral antihistamines for all four major nasal symptoms (congestion, rhinorrhea, sneezing, itching) 3
- Efficacy results from direct topical effects on nasal mucosa, not systemic absorption 4
When Monotherapy Fails
For moderate-to-severe allergic rhinitis inadequately controlled with fluticasone alone, add intranasal azelastine (not oral antihistamines). 1, 3
- Combination fluticasone + azelastine provides >40% relative improvement compared to either agent alone 1, 3, 8
- Available as fixed-dose combination (Dymista): 1 spray per nostril twice daily for patients ≥12 years 8
- Oral antihistamines add no benefit to nasal symptom control when intranasal corticosteroid is already in use 1, 3
For persistent profuse rhinorrhea despite optimal intranasal corticosteroid therapy, add ipratropium bromide 0.03% nasal spray. 1
Common Pitfalls to Avoid
- Do not discontinue when symptoms improve—continue regular use throughout allergen exposure 1, 2
- Do not share bottles—spreads germs via nasal contact 2
- Do not spray in eyes or mouth—nasal use only 2
- Do not use topical decongestants beyond 3 days—causes rebound congestion, unlike fluticasone 1, 3
- Do not delay treatment waiting for allergy testing—start empirically based on clinical diagnosis 3
- Do not use leukotriene receptor antagonists as primary therapy—markedly less effective than intranasal corticosteroids 1, 3
- Do not add oral antihistamines to intranasal corticosteroid regimens—no additional nasal symptom benefit 1, 3
- Do not assume bottle is empty when liquid remains—after labeled number of sprays, each dose may be incomplete 2
Special Populations
Hypertensive Patients
Fluticasone propionate does not increase blood pressure and requires no blood pressure monitoring, unlike oral decongestants. 3, 2
Patients on Multiple Medications
- Generally safe with most prescription and non-prescription medications 2
- Exercise caution with ritonavir and ketoconazole (may increase fluticasone levels) 2